Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,270 | 7,360 | 7,010 | 12,680 | 8,090 |
| Marketable Securities | 0 | 1,920 | 5,510 | 0 | 9,650 |
| Receivables | 80 | 60 | 80 | 40 | 40 |
| Other current assets | 380 | 120 | 180 | 310 | 440 |
| TOTAL | $10,730 | $9,460 | $12,780 | $13,030 | $18,220 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 90 | 160 | 270 | 350 |
| TOTAL | $N/A | $90 | $160 | $270 | $350 |
| Total Assets | $10,930 | $9,800 | $13,200 | $13,540 | $18,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,760 | 4,270 | 4,280 | 2,800 | 4,100 |
| TOTAL | $2,760 | $4,270 | $4,280 | $2,800 | $4,100 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,760 | $4,270 | $4,280 | $2,800 | $4,100 |
| Shareholders' Equity | |||||
| Common Shares | 87,650 | 95,250 | 89,900 | 92,760 | 91,830 |
| Retained earnings | -95,070 | -106,510 | -96,810 | -97,790 | -92,710 |
| Other shareholders' equity | 4,130 | 3,420 | 3,230 | 5,340 | 5,280 |
| TOTAL | $8,170 | $5,520 | $8,920 | $10,740 | $14,710 |
| Total Liabilities And Equity | $10,930 | $9,790 | $13,200 | $13,540 | $18,810 |